Lamisil Dermgel 1 % gel 15 g

Lamisil 1% Gel 15 gel

Therapeutic Indications:

Skin infections caused by dermatophytes or yeasts. These include hand and foot fungi (Tinea pedis, Tinea manum), fungal infections of the skin surface and skin folds (Tinea corporis and Tinea cruris) and Pityriasis versicolor.

Qualitative and quantitative composition:

The active substance is terbinafine.
1 g gel contains 10 mg of Terbinafine base.
For excipients, cf. 'List of excipients.

Pharmaceutical form:

Gel.

Posology and method of administration:

Adults and children over 12 years.
Lamisil Dermgel 1 ;% should be applied once a day in all indications.
The infected skin thoroughly clean and dry prior to placing the gel. A thin layer of gel applied to affected area and the surrounding areas and gently rub.
If intertriginous infections (inframammair, Interdigital, perianal, inguinal), the application area are covered with a bandage, particularly during the night .
Usually the treatment period as follows:
Tinea pedis: 1 week - 1 times a day.
Tinea corporis and Tinea cruris: 1 week - 1 times a day.
Pityriasis versicolor: 1 week - 1 times a day.
usually occurs after a few days to improve the clinical symptoms. By using irregular or premature discontinuation of treatment the risk of renewed infection.
If after 2 weeks still no sign of improvement has occurred, the diagnosis should be made again.
Use in elderly .
Nothing indicates that elderly patients require different dosages or other adverse effects than younger patients exhibit.
use in children. experience with Lamisil
Dermgel 1 % is limited. It is therefore not recommended to use the drug in children younger than 12 years.

This is a medicine, no prolonged use without medical advice, keep away from children, read the leaflet carefully. Ask your doctor or pharmacist. In case of side effects, contact your doctor.

Contraindications:

Hypersensitivity to terbinafine or one of the other ingredients of the product (cf. 'List of excipients).

Special warnings and precautions for use:

Dermgel Lamisil 1% should be used with caution in patients with wounds, such as inflamed lesions, or show sensitive areas of the body, such as the face, because the present alcohol could irritate.
Dermgel Lamisil 1% is for external use. Eye contact should be avoided. In case of contact with eyes, rinse with water.
Stopping treatment is not necessary in the activities of redness, itching or tingling. The appearance of skin rash or serious allergic reactions such as rash or hives however require discontinuation of treatment.

Pregnancy and lactation:

Research on fertility and fetal toxicity in animals has no toxic effect on the light. To date, no case reports of malformations using Dermgel Lamisil 1% in humans. Since clinical trials in pregnant women are very limited, Dermgel Lamisil 1% may not be used during pregnancy unless the potential benefits outweigh the potential risks.
Terbinafine is excreted in breast milk. Mothers may therefore Dermgel Lamisil 1% do not use them while breastfeeding.
Moreover, any contact with the babies with 1% Lamisil Dermgel treatment areas, including the breasts, be avoided.

Side effects:

The side effects included mild transient reactions near the application area. In very exceptional cases, allergic reactions to discontinuation of treatment.
Problems of the cutaneous and subcutaneous tissues.
Very rare (General problems near the application area.
Uncommon (>1/1.000, Sensitizing.
Very rare (

Effects on ability to drive and use machines control:

At present there is no known effect.

Overdose:

There were no reported cases of overdose with Lamisil Dermgel 1%.
In accidental ingestion of the product can convey the same undesirable effects as those observed the oral administration of terbinafine (headache, nausea, upper abdominal pain and dizziness). In this case, if deemed necessary, the stomach emptied. Symptomatic treatment should be instituted.

List of excipients:

Butylhydroxytoluene - Sodium hydroxide - Benzyl - Sorbitan monolaurate - Carbomer 974P - Polysorbate 20 - Isopropyl - Ethanol 96% (v / v) and purified water.

Interaction with other medicinal products and other forms of interaction:

For the topical form
Dermgel Lamisil 1% interactions are not described.

Incompatibilities:

There are no known incompatibilities.